IQN Path is announcing a strategic technical collaboration with City Cancer Challenge (C/Can) to reinforce diagnostic infrastructure and expertise in low- and middle-income countries (LMICs), where access to precision oncology remain mostly limited. The global diagnostic gap Precision medicine in oncology is advancing rapidly, offering patients a growing number of targeted treatments based on individual read more…